Important Dates

  • Fri
    16
    Sep
    2022
    Sun
    18
    Sep
    2022

    EHDN2022 Plenary Meeting

    Bologna

Latest News

Online presentation on the Roche tominersen programme – hosted by EHDN – January 20th, 2022 at 17h CET,

You are cordially invited to attend an online presentation on the Roche tominersen programme on January 20th, 2022 at 17h CET, organised and hosted by EHDN. The meeting will include key findings from the Phase III GENERATION HD1 trial, followed by Q&A, then a panel discussion with recognised experts in the field of HD. […]

Read More…

Novartis Global study endorsed* by EHDN

Study aims and goal: A Randomized, double-blind, placebo-controlled dose range finding study with Open-Label Extension to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of LMI070/branaplam in participants with early manifest HD. No. of study sites: This Phase IIb study aims to recruit stage 1 and 2 participants at sites in Belgium, Canada, France, Germany, Hungary, […]

Read More…